Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesA randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy
Bone , 09/03/09
Rogers A et al. – The results suggest that bone turnover markers are useful for monitoring response to lasofoxifene. Changes occur early and relate to the BMD response.
Related Articles
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09
Relevance Score: 91%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression
Bone , 12/11/09
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone
Bone , 12/11/09
Gene expression profile in osteoclasts from patients with Pagets disease of bone
Bone , 12/11/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
Bone , 12/11/09
Synvisc-One for the treatment of knee osteoarthritis
International Journal of Clinical Rheumatology, 12/07/09
Glenohumeral Chondrolysis After Shoulder Arthroscopy Associated With Continuous Bupivacaine Infusion
Arthroscopy, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor